Papua New Guinea Institute of Medical Research
23
3
4
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
4.3%
1 terminated/withdrawn out of 23 trials
91.7%
+5.2% vs industry average
61%
14 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children
Role: collaborator
Postpartum 8-aminoquinoline Breast Milk Study
Role: collaborator
An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria
Role: collaborator
Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Role: collaborator
Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria
Role: collaborator
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
Role: collaborator
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
Role: collaborator
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy
Role: collaborator
PCV13 in Non-pregnant Papua New Guinean Women
Role: collaborator
Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG
Role: collaborator
Comparison of Two Different Doses of Azithromycin for Treatment of Yaws
Role: collaborator
Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea
Role: collaborator
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
Role: collaborator
A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women
Role: lead
Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
Role: lead
Dual Point-of-care Test for the Diagnosis of Yaws
Role: collaborator
Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity
Role: lead
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
Role: lead
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
Role: collaborator
Artemether-Lumefantrine Clinical Effectiveness Study
Role: lead